Cargando…
MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling
Constitutive STAT3 activation by tyrosine phosphorylation of mutated or amplified tyrosine kinases (pYSTAT3) is critical for cancer initiation, progression, invasion, and motility of carcinoma cells. We showed that AF1q is associated with STAT3 signaling in breast cancer cells. In xenograft models,...
Autores principales: | Park, Jino, Kim, Soojin, Joh, Joongho, Remick, Scot C., Miller, Donald M., Yan, Jun, Kanaan, Zeyad, Chao, Ju-Hsien, Krem, Maxwell M., Basu, Soumit K., Hagiwara, Shotaro, Kenner, Lukas, Moriggl, Richard, Bunting, Kevin D., Tse, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190071/ https://www.ncbi.nlm.nih.gov/pubmed/27259262 http://dx.doi.org/10.18632/oncotarget.9759 |
Ejemplares similares
-
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis
por: Park, Jino, et al.
Publicado: (2015) -
AF1q inhibited T cell attachment to breast cancer cell by attenuating Intracellular Adhesion Molecule-1 expression
por: Park, Jino, et al.
Publicado: (2019) -
Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017) -
The Elongation Complex Components BRD4 and MLLT3/AF9 Are Transcriptional Coactivators of Nuclear Retinoid Receptors
por: Flajollet, Sébastien, et al.
Publicado: (2013) -
Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
por: Li, Wei, et al.
Publicado: (2018)